71
Views
8
CrossRef citations to date
0
Altmetric
Clinical Focus: Diabetes and Concomitant Disorders

Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus

, MD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kohei Kaku. (2017) Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients. Expert Opinion on Drug Safety 16:11, pages 1313-1322.
Read now
Maria Lee & Mary K Rhee. (2015) Sitagliptin for Type 2 diabetes: a 2015 update. Expert Review of Cardiovascular Therapy 13:6, pages 597-610.
Read now

Articles from other publishers (6)

Bo Ahrén. (2021) Glucose‐lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase‐4 inhibition. Journal of Diabetes Investigation 12:7, pages 1128-1135.
Crossref
Fernando Gomez-Peralta, Cristina Abreu, Sara Gomez-Rodriguez, Rafael J. Barranco & Guillermo E. Umpierrez. (2018) Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios. Diabetes Therapy 9:5, pages 1775-1789.
Crossref
Lesley J. Scott. (2017) Sitagliptin: A Review in Type 2 Diabetes. Drugs 77:2, pages 209-224.
Crossref
H Brath, P M Paldánius, G Bader, W M Kolaczynski & P M Nilsson. (2016) Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapy. Nutrition & Diabetes 6:7, pages e217-e217.
Crossref
Yutaka Seino, Hitoshi Kuwata & Daisuke Yabe. (2016) Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives. Journal of Diabetes Investigation 7:S1, pages 102-109.
Crossref
Rita Mohan Dallumal, Siew Siang Chua, David Bin-Chia Wu & Shireene Ratna Vethakkan. (2015) Sitagliptin: Is It Effective in Routine Clinical Practice?. International Journal of Endocrinology 2015, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.